These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16102325)

  • 1. Evaluating antibiograms to monitor drug resistance.
    El-Azizi M; Mushtaq A; Drake C; Lawhorn J; Barenfanger J; Verhulst S; Khardori N
    Emerg Infect Dis; 2005 Aug; 11(8):1301-2. PubMed ID: 16102325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.
    Pakyz AL
    Pharmacotherapy; 2007 Sep; 27(9):1306-12. PubMed ID: 17723084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antibiogram for hospitals with 50+ beds--Alaska, 2002.
    Castrodale L; Hennessy T
    Alaska Med; 2004; 46(4):81-7. PubMed ID: 15999909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital antibiogram: a necessity.
    Joshi S
    Indian J Med Microbiol; 2010; 28(4):277-80. PubMed ID: 20966554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial stewardship.
    Rybak MJ
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):131S-135S. PubMed ID: 17896906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance: action by laboratories today for a cure tomorrow.
    Kanungo R
    Indian J Med Microbiol; 2011; 29(3):205-6. PubMed ID: 21860096
    [No Abstract]   [Full Text] [Related]  

  • 8. Towards a rational antimicrobial testing policy in the laboratory.
    Banaji N; Oommen S
    Indian J Med Microbiol; 2011; 29(3):209-12. PubMed ID: 21860098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.
    Blomberg B; Mwakagile DS; Urassa WK; Maselle SY; Mashurano M; Digranes A; Harthug S; Langeland N
    BMC Public Health; 2004 Oct; 4():45. PubMed ID: 15476559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which antibiotics should we report in an antibiogram, and how?].
    Alós JI; Rodríguez-Baño J
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):737-41. PubMed ID: 20579778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiograms.
    Lamp K
    Pharm Pract Manag Q; 1996 Jul; 16(2):52-6. PubMed ID: 10161612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors contributing to excessive antimicrobial prescribing.
    Ebert SC
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):126S-130S. PubMed ID: 17896905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and use of antimicrobial stewardship resources by spinal cord injury providers.
    Evans CT; Rogers TJ; Burns SP; Lopansri B; Weaver FM
    PM R; 2011 Jul; 3(7):619-23. PubMed ID: 21777860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan.
    Hsueh PR; Ko WC; Wu JJ; Lu JJ; Wang FD; Wu HY; Wu TL; Teng LJ
    J Microbiol Immunol Infect; 2010 Oct; 43(5):452-5. PubMed ID: 21075714
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rising bacterial resistance to common antibiotics in Al Ain, United Arab Emirates.
    Al-Kaabi MR; Tariq WU; Hassanein AA
    East Mediterr Health J; 2011 Jun; 17(6):479-84. PubMed ID: 21796964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the antibiogram be used to assess microbiologic outcomes after antimicrobial stewardship interventions? A critical review of the literature.
    Schulz LT; Fox BC; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):668-76. PubMed ID: 23307516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.
    Jorgensen JH; Hindler JF
    Clin Infect Dis; 2007 Jan; 44(2):280-6. PubMed ID: 17173232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.